tiprankstipranks
Neurotech International Ltd. (AU:NTI)
ASX:NTI
Australian Market
NTI
Neurotech International
RESEARCH TOOLSreports
Want to see AU:NTI full AI Analyst Report?

Neurotech International (NTI) Stock News & Sentiment

11 Followers
Neurotech Director Options Expire Without Exercise
Premium
Company Announcements
Neurotech Director Options Expire Without Exercise
25d ago
NTI
Neurotech Options Lapse, Trimming Potential Future Dilution
Premium
Company Announcements
Neurotech Options Lapse, Trimming Potential Future Dilution
25d ago
NTI
Maybank Securities Exits Substantial Holder Position in Neurotech International
Premium
Company Announcements
Maybank Securities Exits Substantial Holder Position in Neurotech International
29d ago
NTI
Neurotech Showcases Paediatric Neurology Drug NTI164 at Hong Kong Investment Summit
Premium
Company Announcements
Neurotech Showcases Paediatric Neurology Drug NTI164 at Hong Kong Investment Summit
1M ago
NTI
Neurotech Director Mark Davies Increases Indirect Shareholding
Premium
Company Announcements
Neurotech Director Mark Davies Increases Indirect Shareholding
2M ago
NTI
Neurotech clears secondary trading for new share issue
Premium
Company Announcements
Neurotech clears secondary trading for new share issue
2M ago
NTI
Neurotech International Seeks ASX Quotation for 21.4 Million New Shares
Premium
Company Announcements
Neurotech International Seeks ASX Quotation for 21.4 Million New Shares
2M ago
NTI
More AU:NTI News >

NTI News on the Web

Neurotech Showcases Paediatric Neurology Drug NTI164 at Hong Kong Investment Summit
TipRanks News
Bullish
Neurotech opens first site for phase III autism trial
StockHead
Bullish
Neurotech Director Mark Davies Increases Indirect Shareholding
TipRanks News
Bearish
Neurotech clears secondary trading for new share issue
TipRanks News
Neutral
Neurotech International Seeks ASX Quotation for 21.4 Million New Shares
TipRanks News
Bearish
Neurotech to Highlight Paediatric Neurology Pipeline at NWR Virtual Healthcare Conference
TipRanks News
Bearish
Neurotech Flags Risks and Uncertainties in Neurodevelopmental Drug Strategy
TipRanks News
Bearish
Neurotech Investors Back Capital Raisings and Director Participation at General Meeting
TipRanks News
Neutral

News Score - Last 7 Days

Very Positive
AU:NTI
Sector Average
Media Buzz
This Week1 articles
Weekly Average2 articles
News Sentiment
This Week100%
Sector Average79%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is AU:NTI’s Media Buzz Sentiment?
1 articles about AU:NTI were published this week. In an average week, 2 articles are published.
    What is AU:NTI’s weekly average amount of articles?
    In an average week, 2 articles about AU:NTI are published.
      What is AU:NTI’s News Sentiment?
      100% of articles about AU:NTI were positive this week, compared to its sector average of 79%.
        Healthcare Stocks that are Trending in the News
        GOSSGossamer Bio
        RLAYRelay Therapeutics
        ROIVRoivant Sciences
        ILAIsland Pharmaceuticals Ltd
        JUNSJupiter Neurosciences, Inc.
        Showing the stocks with the most bullish news sentiment over the past week